Sernova Biotherapeutics Inc Stock
Stocks
SVA
CA81752F1062
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1250 CAD | -3.85% |
|
-3.85% | -3.85% |
| Market Cap | 47.21M 33.39M 29.2M 26.94M 24.88M 3.18B 48M 322M 126M 1.57B 125M 123M 5.39B | P/E 2026 * |
-4.17x | P/E 2027 * | -3.13x |
|---|---|---|---|---|---|
| Enterprise Value | 47.21M 33.39M 29.2M 26.94M 24.88M 3.18B 48M 322M 126M 1.57B 125M 123M 5.39B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 9.44x |
| Free-Float |
86.84% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -3.85% | ||
| 1 week | -3.85% | ||
| Current month | -7.41% | ||
| 1 month | -13.79% | ||
| 3 months | -32.43% | ||
| 6 months | -16.67% | ||
| Current year | -3.85% |
| 1 week | 0.12 |  | 0.14 |
| 1 month | 0.12 | | 0.17 |
| Current year | 0.12 | | 0.2 |
| 1 year | 0.12 | | 0.21 |
| 3 years | 0.12 | | 0.99 |
| 5 years | 0.12 | | 2.22 |
| 10 years | 0.1 | | 2.87 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jonathan Rigby
CEO | Chief Executive Officer | 58 | 12/08/2024 |
James Parsons
DFI | Director of Finance/CFO | 60 | 11/10/2024 |
David Burke
IRC | Investor Relations Contact | - | 11/10/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
James Parsons
BRD | Director/Board Member | 60 | 19/04/2012 |
Steven Sangha
BRD | Director/Board Member | - | 24/04/2023 |
David Paterson
BRD | Director/Board Member | - | 01/09/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 05-22 | Option | Director | 260,000 | 0.0748% | ||
| 05-22 | Option | Director | 194,229 | 0.0559% | ||
| 05-22 | Option | Chairman | 228,912 | 0.0658% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.85% | -3.85% | -24.24% | -87.24% | 33.39M | |
| +0.82% | +0.99% | -15.32% | +10.65% | 126B | |
| +0.84% | +1.15% | +1.56% | -3.18% | 12.9B | |
| -1.52% | +2.95% | +47.11% | +112.20% | 8.97B | |
| +4.14% | -2.38% | -48.62% | -71.98% | 3.98B | |
| -0.47% | -1.34% | +20.55% | +45.56% | 2.7B | |
| +0.61% | -7.70% | -14.75% | -24.08% | 1.74B | |
| +0.49% | -3.87% | -6.10% | -23.90% | 1.61B | |
| +0.47% | +10.24% | -60.26% | -83.72% | 1.49B | |
| Average | +0.17% | -0.87% | -11.12% | -13.97% | 17.76B | |
| Weighted average by Cap. | +0.74% | +0.91% | -11.00% | +12.14% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 5M 3.54M 3.09M 2.85M 2.64M 337M 5.08M 34.09M 13.39M 166M 13.28M 12.99M 571M |
| Net income | -12.83M -9.07M -7.94M -7.32M -6.76M -865M -13.04M -87.45M -34.34M -426M -34.06M -33.32M -1.47B | -19.77M -13.98M -12.23M -11.28M -10.42M -1.33B -20.1M -135M -52.94M -657M -52.51M -51.36M -2.26B |
| Net Debt | - | - |
Employees
8
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/07/26 | CA$0.1250 | -3.85% | 155,027 |
| 09/07/26 | CA$0.1300 | 0.00% | 110,276 |
| 08/07/26 | CA$0.1300 | 0.00% | 15,100 |
| 07/07/26 | CA$0.1300 | -3.70% | 62,135 |
| 06/07/26 | CA$0.1350 | +3.85% | 24,204 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.1250CAD
Average target price
0.4500CAD
Spread / Average Target
+260.00%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SVA Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
